| 產(chǎn)品編號 | bs-1965R |
| 英文名稱 | Rabbit Anti-KLK4 antibody |
| 中文名稱 | 激肽釋放酶4抗體 |
| 別 名 | Kallikrein 4; 7S nerve growth factor alpha chain; AI2A1; Alpha-NGF; Androgen-regulated message 1; ARM1; EC 3.4.21.-; EMSP 1; EMSP; EMSP1; Enamel Matrix Serine Protease 1; Enamel matrix serine proteinase 1; HK4; Kallikrein 1-related peptidase-like b4; Kallikrein 4 (prostase, enamel matrix, prostate); Kallikrein; Kallikrein L1; Kallikrein like protein 1; Kallikrein like protein 1; Kallikrein related-peptidase 4 (prostase, enamel matrix, prostate); Kallikrein-4; Kallikrein-like protein 1; Kallikrein-related peptidase 4; KLK 4; KLK L1; KLK-L1; KLK4; KLK4_HUMAN; MGC116827; MGC116828; Prostase; Protease Serine 17; PRSS 17; PRSS17; PSTS; Serine protease 17. |
 |
Specific References (1) | bs-1965R has been referenced in 1 publications.
[IF=3.606] Xie, Yongting. et al. Amelogenesis imperfecta in a Chinese family resulting from a FAM83H variation and the effect of FAM83H on the secretion of enamel matrix proteins. CLIN ORAL INVEST. 2022 Nov;:1-11 WB ; Rat.
|
| 研究領(lǐng)域 | 腫瘤 細(xì)胞生物 信號轉(zhuǎn)導(dǎo) 細(xì)胞骨架 細(xì)胞外基質(zhì) |
| 抗體來源 | Rabbit |
| 克隆類型 | Polyclonal |
| 交叉反應(yīng) | (predicted: Human,Mouse,Rat,Rabbit) |
| 產(chǎn)品應(yīng)用 | ELISA=1:5000-10000
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 理論分子量 | 24kDa |
| 細(xì)胞定位 | 分泌型蛋白 |
| 性 狀 | Liquid |
| 濃 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated synthetic peptide derived from human KLK4: 101-200/254 |
| 亞 型 | IgG |
| 純化方法 | affinity purified by Protein A |
| 緩 沖 液 | 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| 保存條件 | Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| 注意事項 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| PubMed | PubMed |
| 產(chǎn)品介紹 |
Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. In some tissues its expression is hormonally regulated. The expression pattern of a similar mouse protein in murine developing teeth supports a role for the protein in the degradation of enamel proteins. Alternate splice variants for this gene have been described, but their biological validity has not been determined. [provided by RefSeq]. Subcellular Location: Secreted. Tissue Specificity: Expressed in prostate. DISEASE: Defects in KLK4 are the cause of amelogenesis imperfecta hypomaturation type 2A1 (AI2A1) [MIM:204700]. AI2A1 is an autosomal recessive defect of enamel formation. The disorder involves both primary and secondary dentitions. The teeth have a shiny agar jelly appearance and the enamel is softer than normal. Brown pigment is present in middle layers of enamel. Similarity: Belongs to the peptidase S1 family. Kallikrein subfamily. Contains 1 peptidase S1 domain. SWISS: Q9Y5K2 Gene ID: 9622 Database links: Entrez Gene: 9622 Human Entrez Gene: 56640 Mouse Omim: 603767 Human SwissProt: Q9Y5K2 Human SwissProt: P00757 Mouse Unigene: 218366 Human Unigene: 42080 Mouse KLK4目前認(rèn)為是前列腺癌等其他腫瘤很有意義的標(biāo)志物。激肽釋放酶KLK是激肽系統(tǒng)的主要限速酶，它是一組存在于多數(shù)組織和體液中的絲氨酸蛋白酶，是一種肽鏈內(nèi)切酶。KLK又稱血管舒緩素，包括15個家族成員。在不同的組織中廣泛表達(dá),具有蛋白水解酶的活性。它特異性的在碳末端切割底物肽，可裂解激肽原釋放具有活性的激肽，由激肽發(fā)揮對心血管系統(tǒng)及腎臟功能的調(diào)節(jié)作用。 組織KLK是一個大的基因家族，主要分布在肺、腎、血管、腦、腎上腺組織，為一種中等大小的糖蛋白。 |
